India Glycols Limited has informed the Exchange regarding 'Please refer to attachment.'.
INDIAGLYCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
India Glycols Limited has received NCLT Allahabad Bench approval to proceed with its demerger scheme. The company will split into two separate entities: Ennature Biopharma Limited (Resulting Company 1) and IGL Spirits Limited (Resulting Company 2). The tribunal has admitted the Second Motion Petition under Sections 230-232 of the Companies Act, 2013 and directed the company to issue notices to regulatory authorities including SEBI, RBI, Income Tax authorities, and stock exchanges. Newspapers publications and 30-day representations period have been mandated. The matter is listed for further proceedings on 21st May 2026. The scheme remains subject to regulatory approvals and a certified copy of the order is awaited.
This marks a significant procedural step in India Glycols' demerger. The stock may see volatility as the market assesses the impact of splitting the company's operations into pharma and spirits divisions. Final approval from NCLT and other regulators is still pending.